Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Medicine Maker
  • Explore

    Explore

    • Latest
    • Features
    • Interviews
    • Business & Trends
    • Technology & Manufacturing
    • Product Profiles
    • White Papers

    Featured Topics

    • Biopharma
    • Small Molecules
    • Cell & Gene
    • Future of Pharma

    Issues

    • Latest Issue
    • Archive
    • Cell and Gene Therapy Supplement
  • Topics

    Topics

    • Drug Discovery
    • Development & Clinical
    • Formulation
    • Drug Delivery
    • Bioprocessing
    • Small Molecules
    • Cell and Gene
    • Facilities & Equipment
    • Outsourcing
    • Packaging
    • Supply Chain
    • Regulation & Standards
  • News & Blogs

    News & Blogs

    • Industry News
    • Research News
    • Blogs
  • Events
    • Live Events
    • Webinars
  • Community & Awards

    Community & Awards

    • Power List
    • Sitting Down With
    • Innovation Awards
    • Company of the Year Awards
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
    • eBooks
Subscribe
Subscribe
The Medicine Maker / Power List / 2017 / Industry Influencers / James Agalloco

James Agalloco

President, Agalloco & Associates

  • Profile

Meet James Agalloco

Passion“Combining scientific principles and engineering insights to innovate in pharmaceutical manufacturing. Other industries have leveraged technology to a far greater extent than have pharmaceuticals, and have made great strides in both quality and efficiency. The biopharmaceutical industry can dramatically improve if it emulates what has been accomplished elsewhere.”Pivotal moment“When I was first asked to present a training course in the early 1980s by a good friend. Training has been a passion of mine ever since, and is a great way to give back what I’ve learned to others.”Change “Too much of what we do is based upon principles that made sense before computers, automation, and robotics. There needs to be a greater willingness to change in industry. So much has changed elsewhere in society, but much of the biopharmaceutical industry is little different from what was when I first joined the industry in the early 1970s. We need to embrace change and not avoid it.”

False

Advertisement

Recommended

False

The Medicine Maker
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.